Prof. Dr. med. Andreas Mamilos began his medical studies at Johannes Gutenberg University in Mainz, Germany, where he commenced his specialty training in Pathology under the guidance of Prof. Dr. Kirkpatrick. 

He advanced his expertise at the University of Regensburg, Bavaria, under Prof. Dr. Evert, where he not only honed his clinical skills but also contributed to pivotal research projects as an academic associate. With comprehensive training spanning medical autopsies, histopathology, cytology, and molecular pathology, Prof. Mamilos brings a rare breadth of expertise to his role. 

His doctoral thesis, which explored the pathomechanisms of macrophages in peritoneal adhesions, exemplifies his commitment to translational research that bridges bench and bedside. 

His research contributions at Regensburg, including work in Graft-versus-Host Disease (GvHD) and the tumor microenvironment, underscore his dedication to advancing medical knowledge in complex disease areas and achieving new therapeutic implementations. Prof. Mamilos has also conducted research on the applications of artificial intelligence (AI) in breast cancer, focusing on tailoring personalized treatment approaches through the evaluation of predictive and prognostic factors of breast carcinoma. 

After 17 years of distinguished work and study in Germany, Prof. Mamilos returned to his homeland to lead the Pathology Department as its new director. In addition to his diagnostic leadership, he is committed to ongoing research collaborations and continues his role as a scientific assistant and lecturer at the University of Regensburg. Prof. Mamilos frequently lectures in Germany, sharing his expertise with students in medicine, dentistry, and molecular biology, and remains an active member of the research community. 

He also lectures in Pathology at the European University of Cyprus.